Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  1983-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/J.1365-2125.1983.TB02239.XPMID 6661352PMCID PMC1428356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil

  2004cited by this paper
• Evaluations of Drug Interactions

  1984cited by this paper
• Stereospecific high-performance liquid chromatographic analysis of warfarin in plasma.

  1983cited by this paper
• Clinical Pharmacokinetics: Concepts and applications.

  1983cited by this paper
• Kinetics of drug displacement interactions

  1981cited by this paper
• Effect of saturable binding on the pharmacokinetics of drugs: a simulation

  1980cited by this paper
• Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man.

  1980cited by this paper
• Stereospecific assay for (-)- and (+)-propranolol in human and dog plasma.

  1980cited by this paper
• Racemic warfarin and trimethoprim-sulfamethoxazole interaction in humans.

  1979cited by this paper
• Regioselective and stereoselective hydroxylation of R and S warfarin by different forms of purified cytochrome P-450 from rabbit liver.

  1978cited by this paper
• Stereochemical biotransformation of warfarin as a probe of the homogeneity and mechanism of microsomal hydroxylases.

  1977cited by this paper
• The stereoselective interaction of warfarin and metronidazole in man.

  1976cited by this paper
• Warfarin-stereochemical aspects of its metabolism by rat liver microsomes.

  1976cited by this paper
• A physiological approach to hepatic drug clearance

  1975cited by this paper
• Commentary: a physiological approach to hepatic drug clearance.

  1975cited by this paper
• Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.

  1974cited by this paper
• Kinetics of warfarin absorption in man

  1973cited by this paper
• Plasma half‐lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man *

  1973cited by this paper
• THE METABOLIC FATE OF WARFARIN: STUDIES ON THE METABOLITES IN PLASMA *

  1971cited by this paper
• KINETICS AND CLINICAL IMPORTANCE OF DISPLACEMENT OF WARFARIN FROM ALBUMIN BY ACIDIC DRUGS *

  1971cited by this paper
• Comparative pharmacokinetics of coumarin anticoagulants. V. Kinetics of warfarin elimination in the rat, dog, and rhesus monkey compared to man.

  1969cited by this paper
• Potentiation of anticoagulant effect of warfarin by phenylbutazone.

  1967cited by this paper
• A comparison of the isomers of warfarin

  1966cited by this paper

• An Overview of Anticoagulant Drugs Pharmacology, Therapeutic Approaches, Limitations and Perspectives.

  2026cites this paper
• Construction of a fused grid-based template system of CYP2C9 and its application.

  2022cites this paper
• Adverse Drug Events, Medication Errors, and Drug Interactions

  2019cites this paper
• CONCOMITANT USE OF NON-STEROIDAL ANTIINFLAMMATORY DRUGS (NSAIDS) WITH WARFARIN

  2018cites this paper
• Pharmacogenetics of Adverse Drug Reactions.

  2018cites this paper
• Pharmacokinetic and pharmacodynamic interactions of aspirin with warfarin in beagle dogs

  2016cites this paper
• Carbonyl reduction of warfarin: Identification and characterization of human warfarin reductases.

  2016cites this paper
• Brief Report: Significant Decreases in Both Total and Unbound Lopinavir and Amprenavir Exposures During Coadministration: ACTG Protocol A5143/A5147s Results.

  2015influential citation
• Significant Decreases in both Total and Unbound Lopinavir and Amprenavir Exposures during Co-administration: ACTG Protocol A5143/A5147s Results

  2015cites this paper
• Oral anticoagulation: a critique of recent advances and controversies.

  2015cites this paper
• Studies on drug-human serum albumin binding: the current state of the matter.

  2015cites this paper
• Human serum albumin: from bench to bedside.

  2012cites this paper
• General Principles of Pharmacokinetics and Pharmacodynamics

  2011cites this paper
• Lack of pharmacokinetic and pharmacodynamic interactions of roflumilast with (R, S)-warfarin in healthy adult subjects.

  2011cites this paper
• Regulatory and Development Considerations of Chiral Compounds

  2010cites this paper
• Mechanisms and Consequences of Drug–Drug Interactions

  2010cites this paper
• Quantitative clinical pharmacology is transforming drug regulation

  2010influential citation
• Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin.

  2010cites this paper
• Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects.

  2010cites this paper
• Prediction of human disposition toward S-3H-warfarin using chimeric mice with humanized liver.

  2009cites this paper
• Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats

  2009cites this paper
• Evaluation of a Potential Tigecycline‐Warfarin Drug Interaction

  2008cites this paper
• Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects

  2008cites this paper
• Warfarin maintenance dose adjustment with indirect pharmacodynamic model in rats.

  2007cites this paper
• Supercritical fluid chromatography-tandem mass spectrometry for fast bioanalysis of R/S-warfarin in human plasma.

  2006cites this paper
• Comparative Pharmacokinetics of Vitamin K Antagonists

  2005cites this paper
• Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of racemic warfarin in healthy subjects.

  2005cites this paper
• Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.

  2005cites this paper
• Usefulness of coadministration of bucolome in warfarin therapy: pharmacokinetic and pharmacodynamic analysis using outpatient prescriptions.

  2005cites this paper
• Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man

  2004influential citation
• Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.

  2004cites this paper
• A comparison of the relative sensitivities of factor VII and prothrombin time measurements in detecting drug interactions with warfarin

  2004cites this paper
• Lack of effect of cimetidine on pharmacodynamics and kinetics of single oral doses of R- and S-acenocoumarol

  2004cites this paper
• Effect of Herbal Medicines on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects

  2004cites this paper
• The influence of cyclo-oxygenase specificity of non-steroidal anti-inflammatory drugs on bleeding complications in concomitant coumarine users.

  2003cites this paper
• Stereoselective interaction between piroxicam and acenocoumarol.

  2003cites this paper
• Investigation of multiple dose citalopram on the pharmacokinetics and pharmacodynamics of racemic warfarin.

  2003cites this paper
• Analysis of Drug Interaction on Diazepam Binding Site of Human Serum Albumin : Screening of Drugs Binding to Diazepam Binding Site by ELISA for Glycyrrhetic Acid

  2002cites this paper
• Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance

  2002cites this paper
• Effect of the catechol-O-methyltransferase inhibitor entacapone on the steady-state pharmacokinetics and pharmacodynamics of warfarin.

  2002cites this paper
• Changes in plasma protein binding have little clinical relevance

  2002cites this paper
• Warfarin and Ropinirole Interaction

  2001cites this paper
• Hämostasestörungen durch Analgetika, Antiphlogistika und Antirheumatika

  2001influential citation
• INTRODUCING PHARMACOKINETIC AND PHARMACODYNAMIC CONCEPTS*

  2001cites this paper
• Interactions of warfarin.

  2001cites this paper
• The effect of rofecoxib on the pharmacodynamics and pharmacokinetics of warfarin

  2000cites this paper
• RELATIVE IMPACT OF VARIOUS SOURCES OF PHARMACOKINETIC AND PHARMACODYNAMIC VARIABILITY ON WARFARIN RESPONSE

  2000cites this paper
• Effect of the Endothelin‐Receptor Antagonist Bosentan on the Pharmacokinetics and Pharmacodynamics of Warfarin

  1999cites this paper
• The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans

  1999cites this paper
• The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin.

  1998cites this paper
• Lack of Interaction Between Tramadol and Coumarins

  1998cites this paper
• Pharmacokinetic Optimisation of the Treatment of Deep Vein Thrombosis

  1997cites this paper
• Effect of Sertraline on Protein Binding of Warfarin

  1997cites this paper
• Drug Interactions with Aspirin and Other Non-Steroidal Anti-Inflammatory Agents

  1997cites this paper
• Protease Inhibitors in Patients with HIV Disease

  1997cites this paper
• Human P450 metabolism of warfarin.

  1997cites this paper
• Absence of an Effect of Levofloxacin on Warfarin Pharmacokinetics and Anticoagulation in Male Volunteers

  1996cites this paper
• Warfarin Withdrawal

  1996cites this paper
• Potential Interaction between Warfarin and Dicloxacillin

  1996cites this paper
• Stereochemical Aspects of Drug Action and Disposition

  1996cites this paper
• Evaluation of a Potential Enantioselective Interaction Between Ticlopidine and Warfarin in Chronically Anticoagulated Patients

  1995cites this paper
• The Effects of Danshen (Salvia miltiorrhiza) on Warfarin Pharmacodynamics and Pharmacokinetics of Warfarin Enantiomers in Rats

  1995cites this paper
• Warfarin and Nonsteroidal Antiinflammatory Drugs: Why Not?

  1995cites this paper
• Losartan Does Not Affect the Pharmacokinetics and Pharmacodynamics of Warfarin

  1995cites this paper
• Adverse Interactions Between Warfarin and Nonsteroidal Antiinflammatory Drugs: Mechanisms, Clinical Significance, and Avoidance

  1995cites this paper
• Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin.

  1994cites this paper
• Polypharmacy

  1994cites this paper
• NSAID-related adverse drug interactions with clinical relevance. An update.

  1994cites this paper
• Clinically Significant Drug Interactions with the Oral Anticoagulants

  1994cites this paper
• Plasma protein binding displacement interactions--why are they still regarded as clinically important?

  1994cites this paper
• Concomitant etodolac affects neither the unbound clearance nor the pharmacologie effect of warfarin

  1994cites this paper
• Renal handling of warfarin metabolites in man

  1994cites this paper
• Stereochemical aspects of warfarin drug interactions: Use of a combined pharmacokinetic‐pharmacodynamic model

  1994cites this paper
• Polypharmacy. Pharmacokinetic perspectives.

  1994cites this paper
• Chirality and future drug design.

  1993cites this paper
• Determination of the interaction of 3S-hydroxy-10,11-dihydroquinidine on the pharmacokinetics and pharmacodynamics of warfarin.

  1993cites this paper
• Warfarin metabolites: stereochemical aspects of protein binding and displacement by phenylbutazone.

  1993cites this paper
• Adverse Drug Interactions with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

  1993cites this paper
• The Value of Plasma-Warfarin Measurement

  1993cites this paper
• Properties and stereoselectivity of carbonyl reductases involved in the ketone reduction of warfarin and analogues.

  1993cites this paper
• Effect of Moricizine on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Volunteers

  1992cites this paper
• Stereoselective disposition of flurbiprofen in normal volunteers.

  1992cites this paper
• Enantiomers: implications and complications in developmental pharmacology.

  1992cites this paper
• Model to Detect Warfarin-Drug Interactions in Man

  1992cites this paper
• Measurement of the (R)- and (S)-isomers of warfarin in patients undergoing anticoagulant therapy.

  1992cites this paper
• Chiral stereoisomeric molecules in the treatment of arthritis.

  1991cites this paper
• Molecular asymmetry and its pharmacological consequences.

  1991cites this paper
• Further insight into the stereoselective interaction between warfarin and cimetidine in man.

  1991cites this paper
• Prediction of the clinical efficacy of and intolerance to antirheumatic drug therapy

  1991cites this paper
• Implications of Stereoselectivity in Clinical Pharmacokinetics

  1991cites this paper
• The physician scientist.

  1991cites this paper
• Anatomy past and present.

  1991cites this paper
• Azapropazone and warfarin.

  1991cites this paper
• Investigations into thepotential effects ofmultiple doseketorolac on thepharmacokinetics andpharmacodynamics ofracemic

  1990cites this paper
• Clinical Pharmacokinetics 1990

  1990cites this paper
• Determination of the plasma protein binding of the coumarin anticoagulants phenprocoumon and its metabolites, warfarin and acenocoumarol, by ultrafiltration and high-performance liquid chromatography.

  1990cites this paper
• Investigations into the potential effects of multiple dose ketorolac on the pharmacokinetics and pharmacodynamics of racemic warfarin.

  1990cites this paper
• Enantiomer specific pharmacokinetics.

  1990cites this paper
• Norfloxacin Does Not Alter Warfarin's Disposition or Anticoagulant Effect

  1990cites this paper
• Chirality: Pharmacological Action and Drug Development

  1990cites this paper